Metraipolis › archive › dc_f640c52ba75e
Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer — Europe PMC PMID:41848905
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41848905
- DOI
- 10.1007/s00508-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T07:31:29.139Z
- SHA-256 of the archived text
7f53fac7ab619fe07af182998fe6326f8606779bb1eba5776bd4d1c992ca9872- Stable URL of this page
https://metraipolis.com/documento/dc_f640c52ba75e
How to cite
Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer — Europe PMC PMID:41848905 — Europe PMC (en), https://europepmc.org/article/MED/41848905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f640c52ba75e (Metraipolis archive dc_f640c52ba75e, sha256 7f53fac7ab619fe07af182998fe6326f8606779bb1eba5776bd4d1c992ca9872)
BibTeX
@misc{dcf640c52ba75e,
title = {Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer — Europe PMC PMID:41848905},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41848905},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f640c52ba75e; sha256 7f53fac7ab619fe07af182998fe6326f8606779bb1eba5776bd4d1c992ca9872},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41848905. Agents can read the archived copy with the MCP tool read_document.